Register Now
Why register?
 The leading web portal for pharmacy resources, news, education and careers March 2, 2015
Pharmacy Choice - February 2015 Newsletter - March 2, 2015

Pharmacy Choice Newsletter - February 2015

The Pharmacy Spotlight - February 2015
February 5, 2015
Volume 17, Issue 2
Forward to a Friend
News Pharmacy Careers Resources Education Business Marketplace Login
This newsletter is sponsored by:
Industry Headlines
02/05 – New Breast Cancer Findings Reported from Cancer Institute and Hospital (Ki-67 evaluation at the hottest spot predicts clinical outcome of patients…
02/04 – Investigators from Massachusetts General Hospital Report New Data on Hematology and Oncology (A Critical Look at Local-Regional Management of…
02/03 – Target to open 15 stores this year
01/29 – NACDS Lauds Senate Bill to Open State-Approved Pharmacist Services to Medicare Patients
FDA Resources
Generic Drug Approvals
Paragraph IV Patent Certifications
News Releases
Upcoming Meetings
Office of Generic Drugs
FDA Drug Shortages

Quick Poll
Over the next 5-10 years, do expect oral Factor Xa inhibitors, such as rivaroxaban & edoxaban to replace warfarin?

Want to fill out the poll?
Hot Pharmacy Jobs
Pharmacist, Senior-Supervisor - Inpatient Pharmacy
UC Irvine Health
Orange, CA
UC Irvine Health
PharMEDium Services LLC
Memphis, TN
PharMEDium Services LLC
Certified Pharmacy Technicians - Evening Shift
Express Scripts
Tempe, AZ
Express Scripts
Pharmacist Position for Willow Analyst
Rx Pro Health
Vancouver, WA

Choose from Pharmacy Jobs Nationwide with Rx Pro Health. Apply Now!
February Disease Focus
New FDA Labeling Requirements for Pregnancy and Lactation
by Gina D. Moore, PharmD, MBA
Counseling a pregnant or breastfeeding woman about medication use is about to get easier. Pregnant women take an average of three to five drugs during pregnancy, both for pre-existing and new conditions, yet presentation of safety and risk information of those drugs has been relatively difficult to find, at least within the standard product labeling, or package insert. New labeling requirements issued by the FDA in early… Read More
Hot Topic
FDA Approves Edoxaban (Savaysa®)
Darrell Hulisz, RPh, PharmD, Associate Professor, CWRU, School of Medicine and
Kirsten Donnan Doctor of Pharmacy Candidate, ONU College of Pharmacy

Edoxaban (Savaysa®) is a highly specific inhibitor of factor Xa in the clotting cascade. It was approved by the FDA on January 8th, 2015 for the prevention of stroke and systemic embolism in patients with nonvalvular atrial fibrillation and for treatment of deep vein thrombosis and pulmonary embolism. Edoxaban was first introduced … Read More
Last Month's Poll
In your practice, how often do you dispense or recommend a prescription product for insomnia?
Daily or Weekly- 68.1%
Monthly - 15.2%
Rarely - 7.6%
Never - 8.9%
Continuing Education for Pharmacy Professionals
Enroll now at for the latest online Live and Enduring Continuing Education.
Inexpensive, easy to access, and excellent content all define the RxSchool Live experience!
Live On-line Webinars
On the Move: A Comprehensive Review of Osteoarthritis, Gout & Rheumatoid Arthritis
Tuesday, February 10, 2015 - 6:00 PM ET, 2.0 credit hours
Skin Infections: Focus on Cellulitis & MRSA
Wednesday, February 11, 2015 - 6:00 PM ET, 2.0 credit hours
Preventing the Next Epidemic: Pre-Diabetes
Sunday, February 15, 2015 - 12:00 PM ET, 2.0 credit hours
RxSchool is accredited by the Accreditation Council for Pharmacy
Education as a provider of continuing pharmacy education.
Featured distance
Drug Therapy Management Series Part I: Cardiovascular Disorders
ACPE Pharmacist UPN#: 0372-0000-14-032-H01-P
ACPE Technician UPN#: 0372-0000-14-032-H01-T
Credits: 5 credit hours
Release Date: January 22, 2014
Expiration Date: January 22, 2017
Fee: $40.00
Audience: Pharmacists, Pharmacy Technicians
For more information,
visit the Course Information Page
RxSchool is accredited by the Accreditation Council for Pharmacy
Education as a provider of continuing pharmacy education.

©2014 Pharmacy Choice (PC) - All rights reserved.
425 S. Cherry St. Suite 200 | Denver, Colorado 80246
Important Notice: The information contained in this newsletter is intended as an informational resource only. View our full disclaimer.
Previous Newsletters
February 2015
January 2015
December 2014
November 2014
October 2014
September 2014
August 2014
July 2014
June 2014
May 2014
April 2014
March 2014

Be seen by thousands of industry eyes.
Advertise in the Pharmacy Choice Newsletter.

Websites »
Copyright © 2009 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement